A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency
Clinical trial NCT05154890 · TERMINATED
Trial details
- NCT number
- NCT05154890
- Sponsor
- Aeglea Biotherapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2023-04-21
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.